Urinary proteomicsa tool for biomarker discovery

Renal Failure

Volumn 32, Issue 2, 2010, Pages 259-268

  Pejcic, Miljana ^a   Stojnev, Slavica ^a   Stefanovic, Vladisav ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Biomarkers; Diagnostics; Kidney disease; Proteomics; Urine

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1B GLYCOPROTEIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA 2 MICROGLOBULIN; BETA DEFENSIN 1; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EOSINOPHIL PROTEIN X; FETUIN A; FIBRINOPEPTIDE A; GLYCOPROTEIN; INTER ALPHA TRYPSIN INHIBITOR; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; KININOGEN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OROSOMUCOID; OSTEOPONTIN; PREALBUMIN; PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 1 INHIBITOR; PROTEIN UBA52; PSORIASIN; SERINE PROTEINASE INHIBITOR; TUMOR MARKER; UBIQUITIN; UNCLASSIFIED DRUG; ZINC ALPHA 2 GLYCOPROTEIN;

BLADDER CANCER; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; EXOSOME; GLOMERULOPATHY; GRAFT DYSFUNCTION; GRAFT REJECTION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY CANCER; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; OVARY CANCER; PATIENT CARE; PREECLAMPSIA; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEOMICS; REVIEW; TREATMENT RESPONSE; URETEROPELVIC JUNCTION OBSTRUCTION; URINARY TRACT CANCER; CHEMISTRY; METHODOLOGY; PREDICTION AND FORECASTING; URINARY TRACT; URINARY TRACT DISEASE;

BIOLOGICAL MARKERS; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEOMICS; URINARY TRACT; UROLOGIC DISEASES;

EID: 77749254856     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860221003599759     Document Type: Review

References (65)

1. Muller GA, Muller CA, Dihazi H. Clinical proteomics-on the long way from bench to bedside. Nephrol Dial Transplant. 2007;22:1297-1300.
2. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007;18:1057-1071.
3. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more then 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006;7:R80.
4. Hortin GL, Sviridov D. Diagnostic potential for urinary proteomics. Pharmacogenomics. 2007;8:237-255.
5. Kumar S, Tsai CJ, Nussinov R. Temperature range of thermodynamic stability for the native state of reversible two-state proteins. Biochemistry. 2003;42:4864-4873.
6. Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics. 2006;5:1760-1771.
7. Dihazi H, Muller G. Urinary proteomics: A tool to discover biomarkers of kidney diseases. Expert Rev Proteomics. 2007;4:39-50.
8. Pisitkun T, Shen RF, Knepper MA. Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA. 2004;101:13368-13373.
9. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198-207.
10. Hanash S. 2-D or not 2-D: Is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting. Proteomics. 2001;1:635-637.
11. Henzel WJ, Billeci TM, Stults JT, Wong SC, Grimley C, Watanabe C. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc Natl Acad Sci USA. 1993;90: 5011-5015.
12. Vidal BC, Bonventre JV, Hong Hsu SI. Towards the application of proteomics in renal disease diagnosis. Clin Sci. 2005; 109:421-430.
13. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005;67:2313-2320.
14. Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, et al. Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics. 2006;6:1066-1076.
15. Ngai HH, Sit WH, Jiang PP, Xu RJ, Wan JM, Thong-boonkerd V. Serial changes in urinary proteome profile of membranous nephropathy: Implications for pathophysiology and biomarker discovery. J Proteome Res. 2006;5: 3038-3047.
16. Ngai HH, Sit WH, Jiang PP, Thongboonkerd V, Wan JM. Markedly increased urinary preprohaptoglobin and haptoglobin in passive Heymann nephritis: A differential proteomics approach. J Proteome Res. 2007;6:3313-3320.
17. Shui H, Huang T, Ka S, Chen P, Lin Y, Chen A. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2008;23:176-185.
18. Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, et al. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant. 2005;5:2479-2488.
19. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg. 2003;237: 660-664.
20. Schaub S, Wilkins JA, Antonovici M, Krokhin O, Weiler T, Rush D, et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant. 2005;5: 729-738.
21. O'Riordan E, Orlova TN, Podust VN, Chander PN, Yanagi S, Nakazato M, et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am J Transplant. 2007;7:930-940.
22. Quintana LF, Solé-Gonzalez A, Kalko SG, Bañon-Maneus E, Solé M, Diekmann F, et al. Urine proteomics to detect biomarkers for chronic allograft dysfunction. J Am Soc Nephrol. 2009;20:428-435.
23. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008;23: 2151-2157.
24. Zhou H, Pisitkun T, Aponte A, Yen PS, Hoffert JD, Yasuda H, et al. Exosomal fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006;70:1847-1857.
25. Pisitkun T, Shen RF, Knepper MA. Identification and pro-teomic profiling of exosomes in human urine. Proc Nat Acad Sci USA. 2004;101:13368-13373.
26. Rogers MA, Clarke P, Noble J, Munro NP, Paul A, Selby PJ, et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: Identification of key issues affecting potential clinical utility. Cancer Res. 2003;63: 6971-6983.
27. Pieper R, Gatlin CL, McGrath AM. Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 2004;4:1159-1174.
28. Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, et al. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol. 2005;16:1126-1134.
29. Lichtenfels R, Dressler SP, Zobawa M, Recktenwald CV, Ackermann A, Atkins D, et al. Systematic comparative protein expression profiling of clear cell renal cell carcinoma: A pilot study based on the separation of tissue specimen by two dimensional electrophoresis. Mol Cell Proteomics. 2009, September 14 [e-pub ahead of print].
30. Vasudev NS, Sim S, Cairns DA, Ferguson RE, Craven RA, Stanley A, et al. Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma. Br J Cancer. 2009;101:1175-1182.
31. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis FI, Gong L, et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol. 2001;158: 1491-1502.
32. Mueller J, Von Eggeling F, Driesch D, Schubert J, Melle C, Junker K. ProteinChip technology reveals distinctive protein expression profiles in the urine of bladder cancer patients. Eur Urol. 2005;47:885-893.
33. Theodorescu D, Wittke S, Ross MM, Walden M, Conaway M, Just I, et al. Discovery and validation of new protein biomarkers for urothelial cancer: A prospective analysis. Lancet Oncol. 2006;7:230-240.
34. Irmak S, Tilki D, Heukeshoven J, Oliveira-Ferrer L, Friedrich M, Huland H, et al. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer. Proteomics. 2005;5:4296-4304.
35. Kageyama S, Isono T, Iwaki H, Wakabayashi Y, Okada Y, Kontani K, et al. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem. 2004;50:857-866.
36. Iwaki H, Kageyama S, Isono T, Wakabayashi Y, Okada Y, Yoshimura K, et al. Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, γ-synuclein, and catechol-o-methyltransferase) identified by proteomic analysis. Cancer Sci. 2004;95:955-961.
37. Kreunin P, Zhao J, Rosser C, Urquidi V, Lubman DM, Goodison S. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res. 2007;6:2631-2639.
38. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honore B, Wolf H, et al. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol. 1996;155: 2105-2112.
39. Kaiser T, Kamal H, Rank A, Kolb HJ, Holler E, Ganser A, et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood. 2004;104:340-349.
40. Comte B, Franceschi C, Sadoulet MO, Silvy F, Lafitte D, Benkoel L, et al. Detection of bile salt-dependent lipase, a 110 kDa pancreatic protein, in urines of healthy subjects. Kidney Int. 2006;69:1048-1055.
41. Polotsky VY, O'Donnell CP. Genomics of sleep-disordered breathing. Proc Am Thorac Soc. 2007;4:121-126.
42. Weeks ME, Hariharan D, Petronijevic Lj, Radon TP, Whiteman HJ, Kocher HM, et al. Analysis of the urine pro-teome in patients with pancreatic ductal adenocarcinoma. Proc Am Thorac Soc. 2008;7-8:1047-1057.
43. Tantipaiboonwong P, Sinchaikul S, Sriyam S, Phutrakul S, Chen ST. Different techniques for urinary protein analysis of normal and lung cancer patients. Proteomics. 2005;5: 1140-1149.
44. Meier M, Kaiser T, Herrmann A, Knueppel S, Hillmann M, Koester P, et al. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis. J Diabetes Complications. 2005;19:223-232.
45. Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, et al. Proteomic analysis for the assessment of diabetic renal damage in humans. Clin Sci (Lond). 2004;107:485-495.
46. Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics. 2005;5:2648-2655.
47. Dihazi H, Muller G, Lindner S, Meyer M, Asif AR, Oellerich M, et al. Characterisation of diabetic nephropathy by urinary proteomic analysis: Identification of a precessed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem. 2007;53:1636-1645.
48. Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, et al. Proteomic identification of urinary biom-arkers of diabetic nephropathy. Diabetes Care. 2007;30: 629-637.
49. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC, et al. Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care. 2007;30:638-643.
50. Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA. Biomarker discovery in human SLE nephritis. Bull NYU Hosp Jt Dis. 2007;65:187-193.
51. Suzuki M, Ross GF, Wiers K, Nelson S, Bennett M, Passo MH, et al. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol. 2007;22: 2047-2057.
52. Mosley KF, Tam WK, Edwards RJ, Crozier J, Pusey CD, Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology. 2006;45: 1497-1504.
53. Decramer S, Uulm Rbig P, Wittke S, Mischak H, Bascands JL, Schanstra JP. Identification of urinary biomarkers by proteomics in newborns: Use in obstructive nephropathy. Contrib Nephrol. 2008;160:127-141.
54. Zimmerli LU, Schiffer E, Zurbig P, Good DM, Kellmann M, Mouis L, et al. Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics. 2008:7: 290-298.
55. Buhimschi IA, Zhao G, Funai EF, Harris N, Sasson IE, Bernstein IM, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol. 2008;199:551. e1-551.e16.
56. Rocchetti MT, Centra M, Papale M, Bortone G, Palermo C, Centonze D, et al. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy. Proteomics. 2008;8:206-216.
57. Woroniecki RP, Orlova TN, Mendelev N, Shatat IF, Hailpern SM, Kaskel FJ, et al. Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am J Nephrol. 2006;26:258-267.
58. Khurana M, Traum AZ, Aivado M, Wells M, Guerrero M, Grall F. Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol. 2006;21:1257-1265.
59. Theodorescu D, Schiffer E, Bauer H, Douwes F, Eichhorn F, Polley R, et al. Discovery and validation of urinary biom-arkers for prostate cancer. Proteomics Clin Appl. 2008;2: 556-570.
60. Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, et al. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH terminal osteopontin fragments for ovarian cancer in urine. Clin Cancer Res. 2006;12:431-441.
61. Coon JJ, Zürbig P, Dakna M, Dominiczak AF, Decramer S, Fliser D, et al. CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl. 2008;2:964-973.
62. Dihazi H, Müller GA. Urinary proteomics: A tool to discover biomarkers of kidney diseases. Expert Rev Proteomics. 2007;4:39-50.
63. Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominicsak A, et al. Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl. 2007;1:148-156.
64. Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93:1054-1061.
65. Vlahou A, Schanstra J, Frokiaer J, El Nahas M, Spasovski G, Mischak H, et al. Establishment of a European network for urine and kidney proteomics. J Proteomics. 2008;71: 490-492.